Mesa Laboratories Inc /Co/: Pay

Mesa Laboratories Inc /Co/ paid its 3 named executives $11.2M in total in FY2025 (Mar). CEO Gary Owens was paid $6.6M of that.

Pay$100 in the stock at the end of FY20 → $53
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Gary OwensCEO and President
FY2025 (Mar)
FY2024 (Mar)
FY2023 (Mar)
FY2022 (Mar)Not disclosed
FY2021 (Mar)Not disclosed
5 years
John SakysVP and Chief Financial Officer
FY2025 (Mar)
FY2024 (Mar)
FY2023 (Mar)
FY2022 (Mar)Not disclosed
FY2021 (Mar)Not disclosed
FY2015 (Mar)Not disclosed
FY2014 (Mar)Not disclosed
FY2013 (Mar)Not disclosed
8 years
Brian ArchboldSVP of Operations and Continuous Improvement
FY2025 (Mar)
FY2024 (Mar)
FY2023 (Mar)
FY2022 (Mar)Not disclosed
FY2021 (Mar)Not disclosed
5 years

CEO pay against the pay peers

In FY2025 (Mar), the median CEO pay of the 7 peers with pay on file was $7.4M. CEO pay of Mesa Laboratories Inc /Co/ for that year is not on file.

  1. 1AtriCure
  2. 2Adaptive Biotechnologies
  3. 3Standard Biotools
  4. 4Veracyte
  5. 5Artivion
  6. 6Cytek Biosciences
  7. 7Cryoport
  8. 8Mesa Laboratories Inc /Co/Not disclosed
  9. 9AzentaNot disclosed
  10. 10BioLife Solutions Inc.Not disclosed
  11. 11Codexis, Inc.Not disclosed
  12. 12HaemoneticsNot disclosed
  13. 13Harvard Bioscience, Inc.Not disclosed
  14. 14Inogen, Inc.Not disclosed
  15. 15Lemaitre VascularNot disclosed
  16. 16Maravai Lifesciences HoldingsNot disclosed
  17. 17NeogenomicsNot disclosed
  18. 18NeogenNot disclosed
  19. 19QuanterixNot disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.